First-line tumour necrosis factor inhibitor (tnfi) treatment is associated with high multi-criteria remission early on compared to treat-to-target in a treatment naive ra cohort

RHEUMATOLOGY(2023)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要